SB202190

Selleck Chemicals

SB202190 (FHPI) [152121-30-7]

9

152121-30-7

Research Use Only

...

SB202190 is a potent p38 MAPK inhibitor targeting p38alpha/beta with IC50 of 50 nM/100 nM in cell-free assays, sometimes used instead of SB 203580 to investigate potential roles for SAPK2a/p38 in vivo. SB202190 inhibits endothelial cell apoptosis via induction of autophagy and heme oxygenase-1. SB202190 significantly suppresses Erastin-dependent ferroptosis.

-80°C

51202000